↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns

   e.g. "Sirolimus", "アダリムマブ"

A　B　C　D　E　F　G　H　 I 　J　K　L　M　N　O　P　Q　R　S　T　U　V　W　X　Y　Z　other

365 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名（臨床試験情報から抽出）   DrugBank   KEGG DRUG *   KEGG GENES *   KEGG PATHWAY   指定難病告示番号 * 
 1   (2r)-2-propyloctanoic acid   -   -   -   -   1件:
2 
 2   (r)-(-)-2-propyloctaroic acid   -   -   -   -   1件:
2 
 3   1.0 miu il-2 per day   Human interleukin-2   -   -   -   1件:
2 
 4   2.0 miu il-2 per day   Human interleukin-2   -   -   -   1件:
2 
 5   250 mg ck-2017357   -   -   -   -   2件:
2,
11 
 6   4-cholesten-3-one, oxime   -   -   -   -   2件:
2,
3 
 7   40 mg ga   -   -   -   -   2件:
2,
13 
 8   40 mg glatiramer acetate   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   2件:
2,
13 
 9   5% glucose water solution   Water   D00001   -   -   1件:
2 
 10   500 mg ck-2017357   -   -   -   -   2件:
2,
11 
 11   [18f] ge-180   -   -   -   -   1件:
2 
 12   [18f]dpa-714 pet   -   -   -   -   1件:
2 
 13   [18f]pbr06   -   -   -   -   1件:
2 
 14   [i-123] adam   Iodide i-123   -   -   -   1件:
2 
 15   Ab1010   Masitinib   D10229   1件: KIT   11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway   6件:
2,
5,
6,
13,
46,
96 
 16   Acetate   Acetate   -   -   -   40件:
1,
2,
6,
10,
13,
35,
40,
46,
49,
51,
60,
64,
70,
71,
73,
75,
76,
78,
81,
83,
85,
86,
88,
90,
96,
97,
113,
145,
156,
162,
171,
206,
222,
224,
225,
235,
265,
288,
298,
299 
 17   Acetylcarnitine   Acetylcarnitine   -   -   -   2件:
2,
265 
 18   Acthar   Corticotropin   D00146   1件: MC2R   5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   6件:
2,
13,
46,
49,
50,
222 
 19   Actos 15 mg   Pioglitazone   D00945, D08378   1件: PPARG   9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer   1件:
2 
 20   Actos 30 mg   Pioglitazone   D00945, D08378   1件: PPARG   9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer   1件:
2 
 21   Actos 45 mg   Pioglitazone   D00945, D08378   1件: PPARG   9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer   1件:
2 
 22   Albumin   -   -   -   -   2件:
2,
51 
 23   Albutein 5%   Human serum albumin   D05424   -   -   1件:
2 
 24   Albúmina humana   -   -   -   -   1件:
2 
 25   Alpha-lipoic acid   Lipoic acid   D00048, D00086   -   -   2件:
2,
13 
 26   Amivita   -   -   -   -   1件:
2 
 27   Amsc   -   -   -   -   1件:
2 
 28   Amx0035   -   -   -   -   1件:
2 
 29   Anakinra   Anakinra   D02934   2件: IL1R1, IL1R2   15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer   15件:
2,
13,
15,
19,
37,
41,
46,
49,
50,
56,
84,
86,
106,
107,
299 
 30   Ap-101   -   -   -   -   1件:
2 
 31   Apo-p001   -   -   -   -   1件:
2 
 32   Arimoclomol   Arimoclomol   D11374   -   -   3件:
2,
15,
19 
 33   Arundic acid   Arundic acid   D06296   -   -   1件:
2 
 34   Astrorx   -   -   -   -   1件:
2 
 35   Autologous adipose-derived mesenchymal stromal cells   -   -   -   -   1件:
2 
 36   Autologous bone marrow mononucleated cells   -   -   -   -   1件:
2 
 37   Autologous bone marrow-derived stem cells   -   -   -   -   1件:
2 
 38   Autologous mesenchymal stem cells   -   -   -   -   5件:
2,
6,
13,
17,
46 
 39   Autologous mesenchymal stem cells (mscs)   -   -   -   -   1件:
2 
 40   Autologous msc-ntf cells   -   -   -   -   1件:
2 
 41   Autologous t-regulatory lymphocytes   -   -   -   -   1件:
2 
 42   Avp-923   -   -   -   -   3件:
2,
6,
13 
 43   Azilect® 1 mg tabletten   Rasagiline   D02562, D08469, D10829   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
2 
 44   Baclofen   Baclofen   D00241   2件: GABBR1, GABBR2   7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway   5件:
2,
10,
13,
18,
149 
 45   Basiliximab   Basiliximab   D03058   1件: IL2RA   11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor   6件:
2,
50,
65,
97,
222,
228 
 46   Betamethasone   Betamethasone   D00244, D00972, D01357, D01402, D01637, D02032, D02286   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   6件:
2,
46,
65,
90,
96,
235 
 47   Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 mg im once a day for four days   Betamethasone   D00244, D00972, D01357, D01402, D01637, D02032, D02286   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
2 
 48   Bhv-0223   -   -   -   -   1件:
2 
 49   Biib050 / kns-760704   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
2 
 50   Biib050/kns-760704   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
2 
 51   Biib067   -   -   -   -   1件:
2 
 52   Biib078   -   -   -   -   1件:
2 
 53   Biib100   -   -   -   -   1件:
2 
 54   Biologic: ic14 (monoclonal antibody against human cd14)   -   -   -   -   1件:
2 
 55   Biotin   Biotin   D00029   -   -   3件:
2,
13,
20 
 56   Blood sample and environmental survey   -   -   -   -   1件:
2 
 57   Blz945   -   -   -   -   1件:
2 
 58   Bosutinib   Bosutinib   D03252   2件: ABL1, SRC   45件: Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection   2件:
2,
67 
 59   Botox 100 unites allergan (pr1)   Botulinum toxin type a   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   1件:
2 
 60   Botox injection   -   -   -   -   1件:
2 
 61   Botulinum toxin type a   Botulinum toxin type a   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   10件:
2,
5,
6,
7,
13,
15,
17,
70,
113,
149 
 62   Botulinum toxin type b   Botulinum toxin type b   D02735   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   3件:
2,
6,
51 
 63   Botulinum toxin type b (myobloc)   Botulinum toxin type b   D02735   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   2件:
2,
6 
 64   Brx-345   -   -   -   -   1件:
2 
 65   Butylphthalide   Butylphthalide   -   -   -   2件:
2,
6 
 66   Caffeine   Caffeine   D00528, D01453   11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A   22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   6件:
2,
6,
46,
78,
96,
97 
 67   Calogen   -   -   -   -   1件:
2 
 68   Cannabis   Medical cannabis   -   -   -   6件:
2,
6,
13,
90,
96,
97 
 69   Cannabis sativa extract oromucosal spray   Medical cannabis   -   -   -   1件:
2 
 70   Cannabis, medical   Medical cannabis   -   -   -   5件:
2,
6,
13,
96,
97 
 71   Canntrust cbd oil (capsule)   -   -   -   -   1件:
2 
 72   Capsaicin   Capsaicin   D00250   1件: TRPV1   2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   6件:
2,
6,
19,
86,
113,
226 
 73   Capsaicin challenge   Capsaicin   D00250   1件: TRPV1   2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   1件:
2 
 74   Carbidopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   8件:
2,
4,
6,
13,
17,
90,
164,
201 
 75   Carbidopa-levodopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   3件:
2,
4,
6 
 76   Carbolithium   -   -   -   -   1件:
2 
 77   Carbolithium*100cps 150mg   -   -   -   -   1件:
2 
 78   Carbonate   Carbonate ion   -   -   -   10件:
2,
13,
17,
19,
46,
75,
96,
127,
235,
299 
 79   Carbonate de lithium   Carbonate ion   -   -   -   1件:
2 
 80   Cc100   -   -   -   -   1件:
2 
 81   Ceftriaxone   Ceftriaxone   D00924, D07659   -   -   3件:
2,
6,
97 
 82   Celecoxib   Celecoxib   D00567   1件: PTGS2   20件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   8件:
2,
3,
34,
46,
70,
89,
161,
271 
 83   Cell-based therapeutics   -   -   -   -   1件:
2 
 84   Cell-based therapy   -   -   -   -   1件:
2 
 85   Cell-based therapy of autologous adipose derived regenerative cells transplanted intraspinally and intrathecally in als patients   -   -   -   -   1件:
2 
 86   Cimetidine   Cimetidine   D00295, D03503   1件: HRH2   3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction   1件:
2 
 87   Cimetidine plus dexpramipexole   Dexpramipexole   D09886   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
2 
 88   Ciprofloxacin   Ciprofloxacin   D00186, D02216   -   -   5件:
2,
60,
96,
97,
299 
 89   Cistanche total glycosides   -   -   -   -   1件:
2 
 90   Ck-2017357   -   -   -   -   1件:
2 
 91   Ck-2017357 (part a)   -   -   -   -   1件:
2 
 92   Ck-2017357 (part b)   -   -   -   -   1件:
2 
 93   Ck-2127107   Reldesemtiv   D11363   1件: TNNC2   1件: Calcium signaling pathway   2件:
2,
3 
 94   Cnm-au8   -   -   -   -   2件:
2,
13 
 95   Coenzyme q10   Ubidecarenone   D01065   -   -   10件:
2,
6,
8,
10,
46,
57,
113,
193,
214,
215 
 96   Colchicina   Colchicine   D00570   9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8   3件: Gap junction, Pathogenic Escherichia coli infection, Phagosome   1件:
2 
 97   Colchicina lirca - 1 mg compresse 60 compresse   Colchicine   D00570   9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8   3件: Gap junction, Pathogenic Escherichia coli infection, Phagosome   1件:
2 
 98   Colchicine   Colchicine   D00570   9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8   3件: Gap junction, Pathogenic Escherichia coli infection, Phagosome   5件:
2,
42,
56,
93,
266 
 99   Colchicine 1 mg oral tablet   Colchicine   D00570   9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8   3件: Gap junction, Pathogenic Escherichia coli infection, Phagosome   1件:
2 
 100   Copegus   Ribavirin   D00423   -   -   1件:
2 
 101   Copper   Copper   -   -   -   4件:
2,
169,
170,
171 
 102   Corticotropin   Corticotropin   D00146   1件: MC2R   5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   7件:
2,
13,
46,
75,
78,
84,
222 
 103   Creatine   Creatine   -   -   -   12件:
1,
2,
5,
6,
8,
13,
46,
49,
50,
113,
156,
201 
 104   Creatine monohydrate   Creatine   -   -   -   4件:
2,
8,
113,
156 
 105   Creatinine   Creatinine   D03600   -   -   3件:
2,
46,
60 
 106   Cu(ii)atsm   -   -   -   -   2件:
2,
6 
 107   Células madre mesenquimales de tejido adiposo autólogo   -   -   -   -   1件:
2 
 108   Células mesenquimales de tejido adiposo   -   -   -   -   1件:
2 
 109   Células troncales hematopoyéticas autólogas adultas extraidas de médula ósea   -   -   -   -   1件:
2 
 110   Daraprim   Pyrimethamine   D00488   -   -   2件:
2,
4 
 111   Darunavir   Darunavir   D03656   -   -   1件:
2 
 112   Datscan   Ioflupane i-123   D10014   -   -   3件:
2,
5,
6 
 113   Deferiprone   Deferiprone   D07416   -   -   5件:
2,
6,
120,
122,
233 
 114   Dexdor   -   -   -   -   4件:
2,
4,
6,
70 
 115   Dexmedetomidine   Dexmedetomidine   D00514, D01205   3件: ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   11件:
2,
4,
6,
21,
34,
70,
113,
212,
215,
226,
280 
 116   Dexpramipexole   Dexpramipexole   D09886   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
2 
 117   Dexpramipexole (dose 1)   Dexpramipexole   D09886   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
2 
 118   Dexpramipexole (dose 2)   Dexpramipexole   D09886   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
2 
 119   Dexpramipexole dichydrochloride   Dexpramipexole   D09886   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
2 
 120   Dextran   Dextran   D00060   -   -   5件:
2,
62,
79,
96,
97 
 121   Dextran sulfate sodium   Dextran   D00060   -   -   1件:
2 
 122   Dextromethorphan   Dextromethorphan   D00848, D03742, D03744   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   9件:
2,
6,
8,
13,
46,
78,
96,
97,
156 
 123   Dextromethorphan hbr and quinidine sulfate   Dextromethorphan   D00848, D03742, D03744   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
2 
 124   Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg   Dextromethorphan   D00848, D03742, D03744   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   2件:
2,
13 
 125   Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg   Dextromethorphan   D00848, D03742, D03744   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   2件:
2,
13 
 126   Dnl747   -   -   -   -   1件:
2 
 127   Dolutegravir   Dolutegravir   D10066   -   -   1件:
2 
 128   Dronabinol   Dronabinol   D00306   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   5件:
2,
13,
46,
271,
298 
 129   Drug: f 18 t807   -   -   -   -   1件:
2 
 130   E0302 (mecobalamin)   Methylcobalamin   D03246   -   -   1件:
2 
 131   Ebixa   Memantine   D04905, D08174   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   3件:
2,
6,
13 
 132   Edaravone   Edaravone   D01552   -   -   2件:
2,
22 
 133   Endocannabinoid palmitoylethanolamide (pea)   Palmidrol   D08328   -   -   1件:
2 
 134   Eperisone   Eperisone   D01671, D07898   -   -   1件:
2 
 135   Epi-589   -   -   -   -   2件:
2,
6 
 136   Eprex   Erythropoietin   D03231   1件: EPOR   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   1件:
2 
 137   Eprex iv sc 1fl 1ml 40000 ui   Erythropoietin   D03231   1件: EPOR   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   1件:
2 
 138   Eprex*1sir 40000ui/ml 1ml   Erythropoietin   D03231   1件: EPOR   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   1件:
2 
 139   Erythropoietin   Erythropoietin   D03231   1件: EPOR   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   8件:
2,
6,
13,
22,
47,
70,
95,
96 
 140   Escitalopram   Escitalopram   D02567, D07704, D07913   1件: SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   3件:
2,
6,
13 
 141   Esketamine   Esketamine   D07283   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   3件:
2,
4,
70 
 142   Ezogabine   Ezogabine   D09569   5件: KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5   6件: Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection   2件:
2,
144 
 143   Fasudil   Fasudil   D07941   2件: ROCK1, ROCK2   22件: Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
2 
 144   Febuxostat   Febuxostat   D01206   1件: XDH   5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism   3件:
2,
6,
13 
 145   Fecal microbiota transplantation   -   -   -   -   5件:
2,
66,
94,
96,
97 
 146   Filgrastim   Filgrastim   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   25件:
2,
6,
13,
25,
26,
28,
34,
35,
40,
41,
42,
45,
46,
49,
51,
60,
62,
65,
96,
113,
164,
283,
284,
285,
331 
 147   Fixed dose combination ciprofloxacin/celecoxib   Ciprofloxacin   D00186, D02216   -   -   1件:
2 
 148   Flx-787-odt   -   -   -   -   1件:
2 
 149   Flx-787-odt (orally disintigrating tablet)   -   -   -   -   1件:
2 
 150   Fycompa   Perampanel   D08964   4件: GRIA1, GRIA2, GRIA3, GRIA4   13件: Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Transcriptional misregulation in cancer, cAMP signaling pathway   2件:
2,
144 
 151   Gdc-0134   -   -   -   -   1件:
2 
 152   Gilenya   Fingolimod   D10001   1件: S1PR1   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   2件:
2,
13 
 153   Glatiramer   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   4件:
2,
13,
96,
156 
 154   Gm604   -   -   -   -   1件:
2 
 155   Gold   Gold   -   -   -   5件:
2,
6,
13,
46,
171 
 156   Gold nanocrystals   Gold   -   -   -   3件:
2,
6,
13 
 157   Granulocyte colony stimulating factor   Filgrastim   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   3件:
2,
36,
85 
 158   Growth hormone   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   11件:
2,
13,
19,
46,
78,
96,
191,
193,
195,
265,
299 
 159   Growth hormone (somatropin)   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   2件:
2,
78 
 160   Gsk1223249   -   -   -   -   2件:
2,
13 
 161   Guana2015   -   -   -   -   1件:
2 
 162   Guanabenz   Guanabenz   D04375   3件: ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   2件:
2,
13 
 163   Guanabenz acetato   Guanabenz   D04375   3件: ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   1件:
2 
 164   Hk-001   -   -   -   -   1件:
2 
 165   Human albumin   Human serum albumin   D05424   -   -   1件:
2 
 166   Human albumin solution   Human serum albumin   D05424   -   -   1件:
2 
 167   Human autologous mesenchymal stem cells   -   -   -   -   2件:
2,
13 
 168   Human neural stem cells   -   -   -   -   2件:
2,
13 
 169   Hynr-cs inj   -   -   -   -   1件:
2 
 170   Hynrcs-allo inj   -   -   -   -   1件:
2 
 171   I-123   Iodide i-123   -   -   -   2件:
2,
6 
 172   Ibudilast   Ibudilast   D01385   8件: CYSLTR1, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PTGIR   16件: Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   2件:
2,
13 
 173   Ic14   -   -   -   -   1件:
2 
 174   Il-2   Human interleukin-2   -   -   -   5件:
2,
46,
49,
56,
96 
 175   Immunoglobulin g1, anti (protein nogo a) (human mus musculus monoclonal heavy chain), disulfide with human mus musculus monoclonal light chain, dimer   -   -   -   -   1件:
2 
 176   Incobotulinum toxin a   -   -   -   -   2件:
2,
6 
 177   Inosine   Inosine   D00054   -   -   4件:
2,
6,
13,
17 
 178   Insulin like growth factor, type 1   -   -   -   -   1件:
2 
 179   Interleukin-2   Human interleukin-2   -   -   -   6件:
2,
35,
49,
55,
65,
97 
 180   Intra venous injection of stem cell   -   -   -   -   1件:
2 
 181   Intrathecal autologous stem cell   -   -   -   -   1件:
2 
 182   Intrathecal injection   -   -   -   -   1件:
2 
 183   Intravenous administration of 1 million of msc   -   -   -   -   1件:
2 
 184   Intravenous administration of 2 million of msc   -   -   -   -   1件:
2 
 185   Intravenous administration of 4 million of msc   -   -   -   -   1件:
2 
 186   Intravenous immunoglobulin   Immune globulin human   -   -   -   16件:
2,
11,
14,
17,
18,
35,
38,
39,
49,
51,
63,
65,
85,
164,
296,
309 
 187   Intraventricular injection   -   -   -   -   1件:
2 
 188   Ioflupane 123i   Ioflupane i-123   D10014   -   -   1件:
2 
 189   Ipl344   -   -   -   -   1件:
2 
 190   Isis 333611   -   -   -   -   1件:
2 
 191   Jevity 1.0   -   -   -   -   1件:
2 
 192   Jevity 1.5   -   -   -   -   1件:
2 
 193   Ketanest-s   -   -   -   -   3件:
2,
4,
70 
 194   Ketocal   -   -   -   -   1件:
2 
 195   Kns-760704   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
2 
 196   L-serine   Serine   D00016   -   -   1件:
2 
 197   Lacosamide   Lacosamide   D07299   2件: SCN3A, SCN9A   1件: Taste transduction   3件:
2,
46,
149 
 198   Lactose   Lactose   D00046, D03226   -   -   6件:
2,
6,
13,
97,
228,
310 
 199   Lenograstim   Lenograstim   D03247   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   3件:
2,
57,
65 
 200   Leuprolide   Leuprolide   D00989, D08113   1件: GNRHR   2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction   5件:
1,
2,
3,
51,
76 
 201   Levetiracetam   Levetiracetam   D00709   1件: SV2A   1件: ECM-receptor interaction   4件:
2,
4,
6,
13 
 202   Levodopa   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   7件:
2,
4,
6,
17,
90,
164,
201 
 203   Levosimendan   Levosimendan   D04720   2件: PDE3A, PDE3B   11件: Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
2 
 204   Lioresal*50cpr 10mg   Baclofen   D00241   2件: GABBR1, GABBR2   7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway   1件:
2 
 205   Lipoic acid   Lipoic acid   D00048, D00086   -   -   5件:
2,
5,
13,
14,
20 
 206   Lithium   Lithium citrate   D04749   -   -   4件:
2,
5,
7,
8 
 207   Lithium carbonate   Lithium carbonate   D00801   -   -   5件:
2,
13,
17,
19,
127 
 208   Lithiumcarbonaat   -   -   -   -   1件:
2 
 209   Lithiumcarbonaat 400 pch tabletten   -   -   -   -   1件:
2 
 210   Litio carbonato   -   -   -   -   1件:
2 
 211   Lunasin regimen   -   -   -   -   1件:
2 
 212   Mannitolo 18%   -   -   -   -   1件:
2 
 213   Mannitolo 18% ldb   -   -   -   -   1件:
2 
 214   Masitinib   Masitinib   D10229   1件: KIT   11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway   6件:
2,
5,
6,
13,
46,
96 
 215   Masitinib (3.0)   Masitinib   D10229   1件: KIT   11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway   1件:
2 
 216   Masitinib (4.5)   Masitinib   D10229   1件: KIT   11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway   1件:
2 
 217   Masitinib (6.0)   Masitinib   D10229   1件: KIT   11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway   1件:
2 
 218   Masitinib mesylate   Masitinib   D10229   1件: KIT   11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway   6件:
2,
5,
6,
13,
46,
96 
 219   Mci-186   Edaravone   D01552   -   -   1件:
2 
 220   Mci-186 in open label phase   Edaravone   D01552   -   -   1件:
2 
 221   Md1003   -   -   -   -   5件:
2,
10,
13,
14,
20 
 222   Mecobalamin   Methylcobalamin   D03246   -   -   1件:
2 
 223   Medicine   -   -   -   -   1件:
2 
 224   Memantine   Memantine   D04905, D08174   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   7件:
2,
6,
8,
13,
49,
127,
205 
 225   Memantine (ebixa)   Memantine   D04905, D08174   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
2 
 226   Memantine hydrochloride   Memantine   D04905, D08174   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   3件:
2,
6,
127 
 227   Mesenchymal stem cell   -   -   -   -   2件:
2,
93 
 228   Mesenchymal stem cells   -   -   -   -   11件:
2,
6,
13,
20,
49,
51,
60,
96,
222,
274,
299 
 229   Methylcobalamin   Methylcobalamin   D03246   -   -   1件:
2 
 230   Methylprednisolone   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   36件:
2,
13,
25,
26,
35,
38,
39,
40,
41,
42,
43,
45,
46,
49,
50,
51,
60,
63,
64,
65,
66,
83,
84,
86,
96,
97,
145,
164,
220,
222,
224,
271,
283,
284,
285,
296 
 231   Mexiletine   Mexiletine   D00639, D08215   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   5件:
1,
2,
10,
113,
114 
 232   Midazolam   Midazolam   D00550, D00696, D05028   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   10件:
2,
3,
6,
13,
46,
70,
96,
97,
231,
298 
 233   Minocycline   Minocycline   D00850, D05045   -   -   13件:
2,
6,
8,
13,
46,
85,
90,
94,
162,
201,
206,
280,
299 
 234   Mn-166   -   -   -   -   1件:
2 
 235   Monitor   Methamidophos   -   -   -   12件:
2,
11,
13,
19,
46,
49,
58,
70,
85,
98,
298,
300 
 236   Monthly autologous treg cells infusions + 3 times per week interleukin-2 injections   Human interleukin-2   -   -   -   1件:
2 
 237   Moxifloxacin   Moxifloxacin   D00874, D08237   -   -   8件:
2,
6,
46,
49,
85,
86,
240,
299 
 238   Msc-ntf cells transplantation (im)   -   -   -   -   1件:
2 
 239   Msc-ntf cells transplantation (it)   -   -   -   -   1件:
2 
 240   Msc_ntf cells transplantation by multiple intramuscular injections at 24 separate sites, in addition to a single intrathechal injection into the csf   -   -   -   -   1件:
2 
 241   Multiple dose   -   -   -   -   1件:
2 
 242   Mycophenolate   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   33件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
84,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 243   Mycophenolate mofetil   Mycophenolate mofetil   D00752, D05094, D05095   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   32件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 244   Myelostim 34*1fl 263mcg+1sir   -   -   -   -   1件:
2 
 245   Myonal*30cpr riv 100mg   -   -   -   -   1件:
2 
 246   Np001   -   -   -   -   1件:
2 
 247   Nuedexta   Dextromethorphan   D00848, D03742, D03744   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
2 
 248   Nurown® (msc-ntf cells)   -   -   -   -   1件:
2 
 249   Odm-109   -   -   -   -   1件:
2 
 250   Odm-109 capsule 1 mg   -   -   -   -   1件:
2 
 251   Olanzapine   Olanzapine   D00454, D06623   11件: ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4, HRH1, HTR2A, HTR2B, HTR2C, HTR6   16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Salivary secretion, Serotonergic synapse, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   2件:
2,
8 
 252   Olesoxime   -   -   -   -   2件:
2,
3 
 253   Ono-2506po   -   -   -   -   2件:
2,
6 
 254   Oral levosimendan   Levosimendan   D04720   2件: PDE3A, PDE3B   11件: Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
2 
 255   Oral nutritional supplementation   -   -   -   -   1件:
2 
 256   Oxepa   -   -   -   -   1件:
2 
 257   Ozanezumab   Ozanezumab   D10331   1件: RTN4   1件: Alzheimer disease   1件:
2 
 258   Palmitoylethanolamide   Palmidrol   D08328   -   -   1件:
2 
 259   Paracetamolo   -   -   -   -   1件:
2 
 260   Pbmc autotransplantation   -   -   -   -   1件:
2 
 261   Perampanel   Perampanel   D08964   4件: GRIA1, GRIA2, GRIA3, GRIA4   13件: Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Transcriptional misregulation in cancer, cAMP signaling pathway   3件:
2,
6,
144 
 262   Perfalgan   -   -   -   -   1件:
2 
 263   Phenylbutyrate   Phenylbutyric acid   D05868   -   -   10件:
2,
3,
6,
8,
93,
94,
244,
251,
297,
299 
 264   Phosphate   Phosphate ion   -   -   -   29件:
2,
3,
11,
12,
13,
28,
36,
46,
49,
51,
53,
60,
62,
65,
70,
78,
81,
83,
90,
96,
97,
164,
235,
256,
283,
284,
285,
286,
299 
 265   Pimozide   Pimozide   D00560   2件: DRD2, DRD3   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
2 
 266   Pimozide 2 mg per day   Pimozide   D00560   2件: DRD2, DRD3   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
2 
 267   Pimozide 2mg/day (current) or 4 mg/day (study initiation)   Pimozide   D00560   2件: DRD2, DRD3   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
2 
 268   Pimozide 4 mg per day   Pimozide   D00560   2件: DRD2, DRD3   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
2 
 269   Pioglitazone   Pioglitazone   D00945, D08378   1件: PPARG   9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer   17件:
2,
6,
13,
15,
20,
46,
49,
65,
67,
78,
81,
86,
96,
229,
265,
298,
299 
 270   Pioglitazone and tretinoin   Pioglitazone   D00945, D08378   1件: PPARG   9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer   1件:
2 
 271   Pleconaril   Pleconaril   D05528   -   -   1件:
2 
 272   Plenur   -   -   -   -   1件:
2 
 273   Pramipexole   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   2件:
2,
6 
 274   Prednisone   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   43件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331 
 275   Probiotic   -   -   -   -   5件:
2,
6,
96,
193,
266 
 276   Proleukin   Aldesleukin   D00748   3件: IL2RA, IL2RB, IL2RG   14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease (IBD), JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor   2件:
2,
49 
 277   Proleukin 18 mui   Aldesleukin   D00748   3件: IL2RA, IL2RB, IL2RG   14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease (IBD), JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor   1件:
2 
 278   Prototype capsule gdc-0134   -   -   -   -   1件:
2 
 279   Pyrimethamine   Pyrimethamine   D00488   -   -   4件:
2,
4,
19,
65 
 280   Q-cells   -   -   -   -   1件:
2 
 281   Quinidine   Quinidine   D00642, D00643, D02272, D08458   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   3件:
2,
8,
13 
 282   R(+) pramipexole dihydrochloride monohydrate   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
2 
 283   Rabeprazole   Rabeprazole   D00724, D08463   2件: ATP4A, ATP4B   4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation   2件:
2,
51 
 284   Ranolazine   Ranolazine   D05700, D05701   -   -   6件:
2,
58,
86,
113,
114,
130 
 285   Ranolazine 1000 mg   Ranolazine   D05700, D05701   -   -   1件:
2 
 286   Ranolazine 500 mg   Ranolazine   D05700, D05701   -   -   1件:
2 
 287   Rapamune   Sirolimus   D00753   1件: MTOR   43件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway   5件:
2,
60,
66,
67,
158 
 288   Rapamune - 1 mg 100 compresse rivestite in blister uso orale   Sirolimus   D00753   1件: MTOR   43件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway   1件:
2 
 289   Rapamycin   Sirolimus   D00753   1件: MTOR   43件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway   16件:
2,
15,
34,
35,
46,
49,
51,
60,
61,
67,
86,
89,
158,
256,
278,
279 
 290   Rasagiline   Rasagiline   D02562, D08469, D10829   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   4件:
2,
5,
6,
17 
 291   Rasagiline mesilate   Rasagiline   D02562, D08469, D10829   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   3件:
2,
5,
6 
 292   Recombinant human erythropoietin(rhepo)   Erythropoietin   D03231   1件: EPOR   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   1件:
2 
 293   Reference capsule gdc-0134   -   -   -   -   1件:
2 
 294   Repository corticotropin injection   Corticotropin   D00146   1件: MC2R   5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   5件:
2,
13,
46,
84,
222 
 295   Requip cr tablets   -   -   -   -   1件:
2 
 296   Retigabine   Ezogabine   D09569   5件: KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5   6件: Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection   2件:
2,
144 
 297   Ribavirin   Ribavirin   D00423   -   -   2件:
2,
96 
 298   Rilutek   Riluzole   D00775   14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway   1件:
2 
 299   Rilutek 50 mg film-coated tablets   Riluzole   D00775   14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway   1件:
2 
 300   Rilutek 50 mg, film-coated tablets   Riluzole   D00775   14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway   1件:
2 
 301   Riluzole   Riluzole   D00775   14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway   7件:
2,
3,
5,
8,
13,
17,
206 
 302   Riluzole 50 mg   Riluzole   D00775   14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway   1件:
2 
 303   Riluzole 50 mg (part b)   Riluzole   D00775   14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway   1件:
2 
 304   Riluzole oral soluble film   Riluzole   D00775   14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway   1件:
2 
 305   Riluzole oral soluble film (rosf) 50 mg   Riluzole   D00775   14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway   1件:
2 
 306   Riluzolo   -   -   -   -   1件:
2 
 307   Ritonavir   Ritonavir   D00427   -   -   4件:
2,
86,
130,
265 
 308   Rns60   -   -   -   -   2件:
2,
13 
 309   Saline solution   -   -   -   -   4件:
2,
34,
288,
299 
 310   Sativex   Dronabinol   D00306   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   2件:
2,
13 
 311   Sb-509   -   -   -   -   1件:
2 
 312   Scopolamine   Scopolamine   D00138   5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   11件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   1件:
2 
 313   Selective serotonin uptake inhibitors (ssri)   Serotonin   -   -   -   1件:
2 
 314   Serine   Serine   D00016   -   -   3件:
2,
6,
86 
 315   Serotonin   Serotonin   -   -   -   1件:
2 
 316   Single dose reduced   -   -   -   -   1件:
2 
 317   Single dose standard   -   -   -   -   1件:
2 
 318   Snn0029   -   -   -   -   1件:
2 
 319   Snn0029 infusion solution   -   -   -   -   1件:
2 
 320   Sodium phenylbutyrate   Phenylbutyric acid   D05868   -   -   4件:
2,
3,
8,
251 
 321   Sodium valproate   Valproic acid   D00399   7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2   17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism   4件:
2,
90,
102,
256 
 322   Somatropin   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   15件:
2,
3,
19,
46,
74,
75,
78,
96,
113,
193,
195,
265,
274,
276,
299 
 323   Spect : 123 i-fp-cit (datscan) and 123i-adam   -   -   -   -   1件:
2 
 324   Spirit1   -   -   -   -   1件:
2 
 325   Stem cell   -   -   -   -   2件:
2,
113 
 326   Stem cell (hpc) implantation   -   -   -   -   1件:
2 
 327   Stem cells   -   -   -   -   4件:
2,
4,
96,
113 
 328   Sulfate   Sulfate ion   -   -   -   22件:
2,
6,
11,
13,
26,
34,
36,
46,
49,
60,
61,
64,
66,
79,
86,
96,
222,
226,
265,
296,
297,
299 
 329   Suspension of human autologous msc 3p in 1,5 ml   -   -   -   -   1件:
2 
 330   Suspension of human autologous msc 3p in 1.5 ml   -   -   -   -   1件:
2 
 331   Tacrolimus   Tacrolimus   D00107, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   29件:
2,
11,
13,
36,
46,
49,
50,
51,
53,
60,
61,
62,
65,
66,
85,
95,
96,
97,
113,
151,
158,
164,
222,
224,
226,
228,
283,
284,
299 
 332   Talampanel   Talampanel   D02696   4件: GRIA1, GRIA2, GRIA3, GRIA4   13件: Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Transcriptional misregulation in cancer, cAMP signaling pathway   2件:
2,
6 
 333   Tamoxifen   Tamoxifen   D00966, D08559   2件: ESR1, ESR2   9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway   4件:
2,
86,
113,
227 
 334   Tamoxifen 40 mg daily for one year   Tamoxifen   D00966, D08559   2件: ESR1, ESR2   9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway   1件:
2 
 335   Tauroursodeoxycholic acid   Tauroursodeoxycholic acid   -   -   -   4件:
2,
13,
93,
299 
 336   Tch346   -   -   -   -   1件:
2 
 337   Tenofovir   Tenofovir   D06074   -   -   5件:
2,
25,
93,
265,
325 
 338   Tenofovir alafenamide   Tenofovir alafenamide   D10428   -   -   1件:
2 
 339   Tenofovir alafenamide (taf)   Tenofovir alafenamide   D10428   -   -   1件:
2 
 340   Testosterone   Testosterone   D00075, D00957, D00958, D00959, D06085, D06087   1件: AR   3件: Oocyte meiosis, Pathways in cancer, Prostate cancer   7件:
1,
2,
3,
13,
78,
113,
265 
 341   Tevagrastim   -   -   -   -   1件:
2 
 342   Thalidomide   Thalidomide   D00754   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   18件:
2,
16,
20,
28,
49,
51,
53,
65,
84,
85,
94,
96,
97,
227,
271,
280,
298,
331 
 343   Thalidomide (drug)   Thalidomide   D00754   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
2 
 344   Tioctic acid   -   -   -   -   1件:
2 
 345   Tirasemtiv   Tirasemtiv   D10327   -   -   1件:
2 
 346   Tocilizumab   Tocilizumab   D02596   1件: IL6R   11件: Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease (NAFLD), PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor   16件:
2,
13,
40,
41,
43,
46,
50,
51,
53,
54,
55,
86,
107,
266,
271,
331 
 347   Tocotrienols   -   -   -   -   1件:
2 
 348   Tretinoin   Tretinoin   D00094   3件: PML, RARA, RARB   12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis   2件:
2,
75 
 349   Tretinoin and pioglitazone hcl   Pioglitazone   D00945, D08378   1件: PPARG   9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer   1件:
2 
 350   Tricyclic antidepressants (tca)   -   -   -   -   1件:
2 
 351   Triheptanoin   Triheptanoin   D11465   -   -   10件:
2,
8,
120,
149,
156,
248,
256,
257,
317,
324 
 352   Triumeq   Lamivudine   D00353   -   -   1件:
2 
 353   Tro19622   Tro19622   -   -   -   3件:
2,
3,
13 
 354   Trobalt   Ezogabine   D09569   5件: KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5   6件: Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection   1件:
2 
 355   Tv-7110   -   -   -   -   1件:
2 
 356   Téralithe lp   -   -   -   -   1件:
2 
 357   Valproate   Valproic acid   D00399   7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2   17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism   6件:
2,
3,
90,
102,
233,
256 
 358   Vitamin e   Vitamin e   D02331   -   -   11件:
2,
6,
13,
20,
46,
90,
96,
97,
206,
299,
317 
 359   Vm202   -   -   -   -   1件:
2 
 360   Water   Water   D00001   -   -   18件:
2,
5,
6,
13,
17,
19,
35,
46,
53,
57,
63,
65,
67,
84,
97,
226,
278,
299 
 361   Yam80   -   -   -   -   1件:
2 
 362   Zibren*20bust 500mg   -   -   -   -   1件:
2 
 363   Zinc   Zinc   -   -   -   4件:
2,
19,
171,
299 
 364   Zinc and copper   Copper   -   -   -   1件:
2 
 365   Zyprexa   Olanzapine   D00454, D06623   11件: ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4, HRH1, HTR2A, HTR2B, HTR2C, HTR6   16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Salivary secretion, Serotonergic synapse, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
2 

先頭へ